“Since our lead drug targets excess pro-inflammatory TNF-alpha, a primary cause of sarcopenia, we believe it could provide a much-needed solution for preserving muscle mass in GLP-1-induced ...

The addition of tumor-necrosis factor-α (TNF-α) to this treatment approach has changed the situation dramatically. High response rates and limb-salvage rates have been reported in multicenter ...

(Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that it ...

Over the last decade, TNF-α antagonists became the most powerful tools for controlling patient suffering from a number of rheumatic diseases. Infliximab, etanercept and adalimumab can induce ...

After hours: December 31 at 4:23:37 PM EST Loading Chart for TNFA ...

The best fleeces now weigh as much as a T-shirt, are more breathable than a merino baselayer, and provide warmth when ...

manchester.ac.uk Objective The British Society for Rheumatology Biologics Register (BSRBR) has collected data on adverse events including pregnancies in patients with rheumatoid arthritis treated with ...

The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform ... an immune ...

Conclusion Our findings emphasise the role of microbiota-derived TNF to kick-start the differentiation and the functional maturation of the neonatal splenic pre-cDC1 compartment. They bring a better ...

The AFC Asia Frontier Fund is invested in Airlink and Systems Limited. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as ...